Precision Dosing Leader Abreos Biosciences Announces New Investment Round
/
DateJun 06 2017
Abreos Biosciences, a San Diego-based biotech company and a leader in the precision dosing of biological therapeutics, is pleased to announce that it has completed a new investment round. The funding came from existing investors as well as new investor TLP Investment Partners LLC and its affiliates.


















